Cargando...
A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma
PURPOSE: Glioblastoma (GBM) is the most common form of brain tumor and has a uniformly poor prognosis. Development of prognostic biomarkers in easily accessible serum samples have the potential to improve the outcomes of patients with GBM through personalized therapy planning. MATERIAL/METHODS: In t...
Gardado en:
| Publicado en: | J Biochem Anal Stud |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057620/ https://ncbi.nlm.nih.gov/pubmed/33884377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.16966/2576-5833.117 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|